http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-84319-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4b043c903ec3d696709ca6140213988 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2013-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b23e21ae9ec55c964c53482903e55019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09a387e2e8dc34b2586a34ce85e70a9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04246d953169c562cba0e2675cd3c873 |
| publicationDate | 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-84319-U |
| titleOfInvention | METHOD FOR ESTIMATING ANTIHYPERTENSIVE THERAPY EFFECTIVENESS IN PATIENTS WITH HYPERTENSIVE DISEASE WITH ABDOMINAL OBESITY IN THE BACKGROUND OF INSULIN RESISTANCE |
| abstract | A method of evaluating the effectiveness of antihypertensive therapy in patients with hypertension with abdominal obesity against insulin resistance involves evaluating endothelial function in the treatment process. In the blood of patients determine the content of orange and nitric oxide. When increasing the content of orange and nitric oxide in relation to previous measurements, the therapy is assessed as effective and continued. In the absence of a tendency to normalize the content of orange and nitric oxide, the therapy is supplemented or modified. |
| priorityDate | 2013-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.